Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Denis Xavier

Showing results (61-70 of 152) with videos related to

Pageof 16
Sort By:
American Heart Journal|February 15, 2011
Design and rationale of the radial versus femoral access for coronary intervention (RIVAL) trial: a randomized comparison of radial versus femoral access for coronary angiography or intervention in patients with acute coronary syndromesSanjit S Jolly, Kari Niemelä, Denis Xavier, et al.
International Journal of Cardiology|January 15, 2020
Regional variation in clinical characteristics and outcomes in patients with atrial fibrillation: Findings from the ARISTOTLE trialM Cecilia Bahit, Christopher B Granger, John H Alexander, et al.
Global Heart|March 25, 2017
The World Heart Federation Roadmap for Nonvalvular Atrial FibrillationAdrianna Murphy, Amitava Banerjee, Günter Breithardt, et al.
American Heart Journal|September 1, 2014
Efficacy and safety of apixaban compared with warfarin for stroke prevention in patients with atrial fibrillation from East Asia: a subanalysis of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) TrialShinya Goto, Jun Zhu, Lisheng Liu, et al.
BMJ (Clinical Research Ed.)|July 5, 2011
Global response to non-communicable disease, Maria Teresa Cerqueira, Alejandro Cravioto, et al.
BMJ (Clinical Research Ed.)|June 17, 2016
Polypharmacy and effects of apixaban versus warfarin in patients with atrial fibrillation: post hoc analysis of the ARISTOTLE trialJeroen Jaspers Focks, Marc A Brouwer, Daniel M Wojdyla, et al.
Indian Heart Journal|August 26, 2015
Prevalence, treatments and outcomes of coronary artery disease in Indians: A systematic reviewMangala Rao, Denis Xavier, Padmini Devi, et al.
The Lancet. Global Health|April 18, 2021
Urgently seeking efficiency and sustainability of clinical trials in global healthJay J H Park, Rebecca F Grais, Monica Taljaard, et al.
American Heart Journal|September 11, 2013
Apixaban versus warfarin in patients with atrial fibrillation according to prior warfarin use: results from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trialDavid A Garcia, Lars Wallentin, Renato D Lopes, et al.
Lancet (London, England)|April 29, 2008
Treatment and outcomes of acute coronary syndromes in India (CREATE): a prospective analysis of registry dataDenis Xavier, Prem Pais, P J Devereaux, et al.
Pageof 16

Showing results (61-70 of 152) with videos related to

Sort By:
Pageof 16
American Heart Journal|February 15, 2011
Design and rationale of the radial versus femoral access for coronary intervention (RIVAL) trial: a randomized comparison of radial versus femoral access for coronary angiography or intervention in patients with acute coronary syndromesSanjit S Jolly, Kari Niemelä, Denis Xavier, et al.
International Journal of Cardiology|January 15, 2020
Regional variation in clinical characteristics and outcomes in patients with atrial fibrillation: Findings from the ARISTOTLE trialM Cecilia Bahit, Christopher B Granger, John H Alexander, et al.
Global Heart|March 25, 2017
The World Heart Federation Roadmap for Nonvalvular Atrial FibrillationAdrianna Murphy, Amitava Banerjee, Günter Breithardt, et al.
American Heart Journal|September 1, 2014
Efficacy and safety of apixaban compared with warfarin for stroke prevention in patients with atrial fibrillation from East Asia: a subanalysis of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) TrialShinya Goto, Jun Zhu, Lisheng Liu, et al.
BMJ (Clinical Research Ed.)|July 5, 2011
Global response to non-communicable disease, Maria Teresa Cerqueira, Alejandro Cravioto, et al.
BMJ (Clinical Research Ed.)|June 17, 2016
Polypharmacy and effects of apixaban versus warfarin in patients with atrial fibrillation: post hoc analysis of the ARISTOTLE trialJeroen Jaspers Focks, Marc A Brouwer, Daniel M Wojdyla, et al.
Indian Heart Journal|August 26, 2015
Prevalence, treatments and outcomes of coronary artery disease in Indians: A systematic reviewMangala Rao, Denis Xavier, Padmini Devi, et al.
The Lancet. Global Health|April 18, 2021
Urgently seeking efficiency and sustainability of clinical trials in global healthJay J H Park, Rebecca F Grais, Monica Taljaard, et al.
American Heart Journal|September 11, 2013
Apixaban versus warfarin in patients with atrial fibrillation according to prior warfarin use: results from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trialDavid A Garcia, Lars Wallentin, Renato D Lopes, et al.
Lancet (London, England)|April 29, 2008
Treatment and outcomes of acute coronary syndromes in India (CREATE): a prospective analysis of registry dataDenis Xavier, Prem Pais, P J Devereaux, et al.
Pageof 16